- Home
- GROW vs TPST Comparison
GROW vs TPST Comparison
Compare GROW & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- TPST
- Stock Information
- Founded
- GROW 1968
- TPST 2011
- Country
- GROW United States
- TPST United States
- Employees
- GROW N/A
- TPST N/A
- Industry
- GROW Investment Managers
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- TPST Health Care
- Exchange
- GROW Nasdaq
- TPST Nasdaq
- Market Cap
- GROW 31.8M
- TPST 33.0M
- IPO Year
- GROW N/A
- TPST N/A
- Fundamental
- Price
- GROW $2.47
- TPST $6.66
- Analyst Decision
- GROW
- TPST Hold
- Analyst Count
- GROW 0
- TPST 3
- Target Price
- GROW N/A
- TPST $30.00
- AVG Volume (30 Days)
- GROW 43.8K
- TPST 72.4K
- Earning Date
- GROW 09-09-2025
- TPST 08-07-2025
- Dividend Yield
- GROW 3.61%
- TPST N/A
- EPS Growth
- GROW N/A
- TPST N/A
- EPS
- GROW 0.01
- TPST N/A
- Revenue
- GROW $8,932,000.00
- TPST N/A
- Revenue This Year
- GROW N/A
- TPST N/A
- Revenue Next Year
- GROW N/A
- TPST N/A
- P/E Ratio
- GROW $230.51
- TPST N/A
- Revenue Growth
- GROW N/A
- TPST N/A
- 52 Week Low
- GROW $2.02
- TPST $5.35
- 52 Week High
- GROW $2.73
- TPST $29.38
- Technical
- Relative Strength Index (RSI)
- GROW 56.26
- TPST 42.36
- Support Level
- GROW $2.35
- TPST $6.57
- Resistance Level
- GROW $2.49
- TPST $7.05
- Average True Range (ATR)
- GROW 0.10
- TPST 0.26
- MACD
- GROW -0.01
- TPST -0.06
- Stochastic Oscillator
- GROW 36.36
- TPST 8.45
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.